Shinya Inoue - SBC Medical Chief Officer
| SBCWW Stock | 0.30 0.02 6.25% |
Executive
Shinya Inoue is Chief Officer of SBC Medical Group
| Address | 200 Spectrum Center Dr., Irvine, CA, United States, 92618 |
| Phone | 949 593 0250 |
| Web | https://sbc-holdings.com |
SBC Medical Management Efficiency
The company has return on total asset (ROA) of 0.1506 % which means that it generated a profit of $0.1506 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.191 %, meaning that it generated $0.191 on every $100 dollars invested by stockholders. SBC Medical's management efficiency ratios could be used to measure how well SBC Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.10 in 2026. Return On Capital Employed is likely to drop to 0.25 in 2026. At this time, SBC Medical's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 35.7 M in 2026, whereas Other Current Assets are likely to drop slightly above 8.2 M in 2026.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jeffrey Appleman | Callan JMB Common | 67 | |
| Chenyang Wang | Greenland Acquisition Corp | 38 | |
| Luyi Wang | Elong Power Holding | 31 | |
| Wiliam McBride | Callan JMB Common | N/A | |
| Ryan Littman | Captivision Ordinary Shares | N/A | |
| Nick Jennings | TOMI Environmental Solutions | 47 | |
| Jing Jin | Greenland Acquisition Corp | 44 | |
| Lin Jia | Guardforce AI Co | 38 | |
| Scott Bullard | Callan JMB Common | N/A | |
| Dana Hopkins | Greenland Acquisition Corp | N/A | |
| Joseph Rzepka | TOMI Environmental Solutions | N/A | |
| Alexander Marcinkowski | Captivision Ordinary Shares | N/A | |
| Shannon Badger | Callan JMB Common | 41 | |
| Anthony CFA | Captivision Ordinary Shares | 61 | |
| Anthony Page | Captivision Ordinary Shares | 61 | |
| MBA FCCA | TOMI Environmental Solutions | 58 | |
| Wei Zou | Elong Power Holding | 55 | |
| David MD | Callan JMB Common | 68 | |
| Yuting Zuo | Guardforce AI Co | 34 | |
| Christopher Shields | Callan JMB Common | 58 | |
| Phei Ho | WF Holding Limited | 40 | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.15 |
SBC Medical Group Leadership Team
Elected by the shareholders, the SBC Medical's board of directors comprises two types of representatives: SBC Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SBC. The board's role is to monitor SBC Medical's management team and ensure that shareholders' interests are well served. SBC Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SBC Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yuji Katayose, Marketing Director | ||
| Ryoji Murata, Principal Officer | ||
| Akiko Wakiyama, Chief Officer | ||
| Akira Komatsu, Chief Secretary | ||
| Taiki Sakaguchi, Corporate Secretary | ||
| Teito Nakagawa, L Co | ||
| Yoshiyuki Aikawa, Chairman CEO | ||
| Kazuki Ichimori, Chief Officer | ||
| Yoshimune Tanaka, Property Director | ||
| Yuya Yoshida, COO Director | ||
| Miki Shimizu, Chief Officer | ||
| Miki Yamazaki, Chief Officer | ||
| Shinya Inoue, Chief Officer | ||
| Hiroyuki Miya, L Co |
SBC Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SBC Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.15 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.37 % | |||
| Number Of Shares Shorted | 22.38 K | |||
| Revenue | 205.42 M | |||
| Gross Profit | 132.23 M | |||
| EBITDA | 77.28 M | |||
| Net Income | 46.61 M | |||
| Total Debt | 12.21 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SBC Stock Analysis
When running SBC Medical's price analysis, check to measure SBC Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SBC Medical is operating at the current time. Most of SBC Medical's value examination focuses on studying past and present price action to predict the probability of SBC Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SBC Medical's price. Additionally, you may evaluate how the addition of SBC Medical to your portfolios can decrease your overall portfolio volatility.